Shandong Weigao Group Medical SHWGF Stock
Shandong Weigao Group Medical Price Chart
Shandong Weigao Group Medical SHWGF Financial and Trading Overview
| Shandong Weigao Group Medical stock price | 0.42 USD |
| Previous Close | 0.42 USD |
| Open | 0.43 USD |
| Bid | 0.42 USD x 750000 |
| Ask | 0.42 USD x 750000 |
| Day's Range | 0.43 - 0.43 USD |
| 52 Week Range | 0.4 - 0.76 USD |
| Volume | 1.73K USD |
| Avg. Volume | 438 USD |
| Market Cap | 1.89B USD |
| Beta (5Y Monthly) | 0.378 |
| PE Ratio (TTM) | 10.5 |
| EPS (TTM) | 0.04 USD |
| Forward Dividend & Yield | 0.02 (5.34%) |
| Ex-Dividend Date | October 21, 2026 |
| 1y Target Est | N/A |
SHWGF Valuation Measures
| Enterprise Value | -736175744 USD |
| Trailing P/E | 10.5 |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | 0.71 |
| Price/Sales (ttm) | 0.13871227 |
| Price/Book (mrq) | 0.5333231 |
| Enterprise Value/Revenue | -0.054 |
| Enterprise Value/EBITDA | -0.27 |
Trading Information
Shandong Weigao Group Medical Stock Price History
| Beta (5Y Monthly) | 0.378 |
| 52-Week Change | -44.73% |
| S&P500 52-Week Change | 14.57% |
| 52 Week High | 0.76 USD |
| 52 Week Low | 0.4 USD |
| 50-Day Moving Average | 0.42 USD |
| 200-Day Moving Average | 0.53 USD |
SHWGF Share Statistics
| Avg. Volume (3 month) | 438 USD |
| Avg. Daily Volume (10-Days) | 410 USD |
| Shares Outstanding | 4.44B |
| Float | 2.36B |
| Short Ratio | N/A |
| % Held by Insiders | 47.71% |
| % Held by Institutions | 21.18% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0.145 |
| Trailing Annual Dividend Yield | 34.52% |
| 5 Year Average Dividend Yield | 136.00% |
| Payout Ratio | 0.5249 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2025 |
| Most Recent Quarter (mrq) | June 30, 2026 |
| Next Fiscal Year End | December 31, 2026 |
Profitability
| Profit Margin | 10.13% |
| Operating Margin (ttm) | 16.48% |
| Gross Margin | 45.56% |
| EBITDA Margin | 20.05% |
Management Effectiveness
| Return on Assets (ttm) | 3.13% |
| Return on Equity (ttm) | 5.68% |
Income Statement
| Revenue (ttm) | 13.59B USD |
| Revenue Per Share (ttm) | 3 USD |
| Quarterly Revenue Growth (yoy) | 3.10% |
| Gross Profit (ttm) | 6.19B USD |
| EBITDA | 2.73B USD |
| Net Income Avi to Common (ttm) | 1.38B USD |
| Diluted EPS (ttm) | 0.04 |
| Quarterly Earnings Growth (yoy) | -23.20% |
Balance Sheet
| Total Cash (mrq) | 8.49B USD |
| Total Cash Per Share (mrq) | 1.87 USD |
| Total Debt (mrq) | 4.07B USD |
| Total Debt/Equity (mrq) | 15.57 USD |
| Current Ratio (mrq) | 3.09 |
| Book Value Per Share (mrq) | 0.7875151 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 2.75B USD |
| Levered Free Cash Flow (ttm) | 1.28B USD |
Profile of Shandong Weigao Group Medical
| Country | United States |
| State | N/A |
| City | Weihai |
| Address | 1 Weigao Road |
| ZIP | 264210 |
| Phone | 86 400 646 6666 |
| Website | https://www.weigaogroup.com |
| Industry | Medical Instruments & Supplies |
| Sector(s) | Healthcare |
| Full Time Employees | 13310 |
Shandong Weigao Group Medical Polymer Company Limited engages in the research and development, production, wholesale, and sale of medical devices in the People's Republic of China and internationally. It operates through Medical Device Products, Orthopedic Products, Pharma Packaging Products, Interventional Products, Blood Management Products, and Others segments. The company offers medical device products, including safe infusion, clinical nursing, perioperative, endocrine, urinary, rehabilitation system, and extracorporeal circulation solutions; pharma packaging products comprising prefilled drug delivery system, pharmaceutical packaging consumables, and automatic drug delivery systems; and orthopedic products that include spine, joint, trauma, sports medicine, bone repair material, and spinal endoscope products, as well as orthopedic devices, PRP treatment consumables, and negative pressure drainage consumables. It also provides interventional products, such as tumor, vascular, and nursing interventions, as well as blood management products, including whole blood collection consumables and blood transfusion equipment. In addition, the company manufactures and sells medical PVC granules, plastic packing bags, and carton boxes; manufacture and sale of medical polymer materials and products; injection puncture instruments; computer technical services; and X-ray based irradiation machines. Further, it provides finance leasing, factoring, and consulting services. The company was founded in 1988 and is based in Weihai, the People's Republic of China.
Q&A For Shandong Weigao Group Medical Stock
What is a current SHWGF stock price?
Shandong Weigao Group Medical SHWGF stock price today per share is 0.42 USD.
How to purchase Shandong Weigao Group Medical stock?
You can buy SHWGF shares on the OTC Markets OTCPK exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Shandong Weigao Group Medical?
The stock symbol or ticker of Shandong Weigao Group Medical is SHWGF.
Which industry does the Shandong Weigao Group Medical company belong to?
The Shandong Weigao Group Medical industry is Medical Instruments & Supplies.
How many shares does Shandong Weigao Group Medical have in circulation?
The max supply of Shandong Weigao Group Medical shares is 4.49B.
What is Shandong Weigao Group Medical Price to Earnings Ratio (PE Ratio)?
Shandong Weigao Group Medical PE Ratio is 10.50000000 now.
What was Shandong Weigao Group Medical earnings per share over the trailing 12 months (TTM)?
Shandong Weigao Group Medical EPS is 0.04 USD over the trailing 12 months.
Which sector does the Shandong Weigao Group Medical company belong to?
The Shandong Weigao Group Medical sector is Healthcare.


